Skip to main content
Fig. 2 | Infectious Agents and Cancer

Fig. 2

From: Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 study)

Fig. 2

The prognosis of patients with HIV-associated Burkitt lymphoma. The overall survival (A) and progression-free survival (B) of low-, intermediate- and high-risk subgroups. The overall survival (C) and progression-free survival (D) of central nervous system involvement. The overall survival (E) and progression-free survival (F) of patients with LDH > 3x ULN. ULN, upper limit of normal

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us